Endophytic bacteria, such as Streptomyces, have the potential to act as a source for novel bioactive molecules with medicinal properties. The present study was aimed at assessing the antimalarial activity of crude extract isolated from various strains of actinobacteria living endophytically in some Malaysian medicinal plants. Using the four day suppression test method on male ICR strain mice, compounds produced from three strains of Streptomyces (SUK8, SUK10, and SUK27) were tested in vivo against Plasmodium berghei PZZ1/100 in an antimalarial screen using crude extracts at four different concentrations. One of these extracts, isolated from Streptomyces SUK10 obtained from the bark of Shorea ovalis tree, showed inhibition of the test organism and was further tested against P. berghei-infected mice for antimalarial activity at different concentrations. There was a positive relationship between the survival of the infected mouse group treated with 50 µg/kg body weight (bw) of ethyl acetate-SUK10 crude extract and the ability to inhibit the parasites growth. The parasite inhibition percentage for this group showed that 50% of the mice survived for more than 90 days after infection with the parasite. The nucleotide sequence and phylogenetic tree suggested that Streptomyces SUK10 may constitute a new species within the Streptomyces genus. As part of the drug discovery process, these promising finding may contribute to the medicinal and pharmaceutical field for malarial treatment.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Abdulelah, H.A. and Zainal-Abidin, B.A.H. 2007. In vivo antimalarial test of Nigeila sativa (black seed). Am. J. Pharmacol. Toxicol. 2, 46–50.
Adamczeski, M., Reed, A.R., and Crews, P. 1995. New and known diketopiperazines from the Caribbean sponge, Calyx cf. podatypa. J. Nat. Prod. 58, 201–208.
Anthony, P.J., Fyfe, L., and Smith, H. 2005. Plant active components- a source for anti-parasitic agents. Trend Parasitol. 21, 462–468.
Ata-ur-Rehman, S., Malik, H., Cun, H., and Clardy, J. 1985. Isolation and structure determination of nigellicine, a novel alkaloid from seeds of Nigella sativa. Tetrahedron Lett. 26, 2759–2762.
Behal, V. 2000. Bioactive products from Streptomyces. Adv. Appl. Microbiol. 47, 113–157.
Belin, P., Moutiez, M., Lautru, S., Seguin, J., Pernodet, J.L., and Gondry, M. 2012. The nonribosomal synthesis of diketopiperazines in tRNA-dependent cyclodipeptide synthase pathways. Nat. Prod. Rep. 29, 961–979.
Ben Ameur Mehdi, R., Mellouli, L., Chabchoub, F., Fotso, S., and Bejar, S. 2004. Purification and structure elucidation of two biologically active molecules from a new isolated Streptomyces sp. US24 strain. Chem. Nat. Comp. 40, 510–513.
Berdy, J. 2005. Bioactive microbial metabolites. J. Antibiot. 58, 1–26.
Bibb, M.J. 2005. Regulation of secondary metabolism in Streptomycetes. Curr. Opin. Microbiol. 8, 208–215.
Bin, Y., Junde, D., Xuefeng, Z., Xianwen, Y., Kyung, J.L., Lishu, W., Si, Z., and Yonghong, L. 2009. Proline-containing dipeptides from a marine sponge of a Callyspongia species. Helv. Chim. Acta. 92, 1112–1117.
Bray, P.G., Ward, S.A., and O’Neill, P.M. 2005. Quinolines and artemisinin: chemistry, biology and history. Curr. Top. Microbiol. Immunol. 295, 3–38.
Castillo, U.F., Strobel, G.A., Ford, E.J., Hess, W.M., Porter, H., Jensen, J.B., Albert, H., Robison, R., Condron, M.A.M., Teplow, D.B., et al. 2002. Munumbicins, wide spectrum antibiotics produced by Streptomyces (NRRL 30562) endophytic on Kennedia nigriscans. Microbiology 148, 2675–2685.
Coombs, J.T. and Franco, M.M. 2003. Isolation and identification of Actinobacteria from surface-sterilized wheat roots. Appl. Environ. Microbiol. 69, 5603–5608.
Ekasari, W., Widyawaruyanti, A., Zaini, N.C., Syafruddin, D., Honda, T., and Morita, H. 2009. Antimalarial activity of Cassiarin from the leaves of Cassia siamea. Heterocycles 78, 1831–1836.
Ernest, E.M.C. 1995. Advantages and limits of in-vivo screening test. Ann. Occup. Hygiene 39, 727–735.
Espinel, M.A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S.J., Reniero, A., Hoffner, S., Rieder, H.L., Binkin, N., Dye, C., et al. 2001. Global trends in resistance to antituberculosis drugs. N. Engl. J. Med. 344, 1294–1303.
Fernandez, L.S., Buchanan, M.S., Carroll, A.R., Feng, Y.J., Quinn, R.J., and Avery, V.M. 2009. Flinderoles A-C: Antimalarial bisindole alkaloids from Flindersia species. Org. Lett. 11, 329–332.
Fiedler, H.P., Bruntner, C., Bull, A.T., Ward, A.C., Goodfellow, M., Potterat, O., Puder, C., and Mihm, G. 2005. Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek 87, 37–42.
Flärdh, K. and Buttner, M.J. 2009. Streptomyces morphogenetics: dissecting differentiation in a filamentous bacterium. Nat. Rev. Microbiol. 7, 36–49.
Foley, M. and Tilley, L. 1998. Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 79, 55–87.
Ghadin, N., Zin, N.M., Sabaratnam, V., Badya, N., Basri, D.F., Lian, H.H., and Sidik, N.M. 2008. Isolation and characterization of a novel endophytic Streptomyces SUK 06 with antimicrobial activity from Malaysian plants. Asian J. Plant Sci. 7, 189–194.
Ibrahim, J., Mat Ali, R., and Goh, S.H. 1994. Toxic and antifungal properties of the essential oils of Cinnamomum species from Peninsular Malaysia. J. Trop. Forest Sci. 6, 286–292.
Isaka, M., Jaturapat, A., Kramyu, J., Tanticharoen, M., and Thebtaranonth, Y. 2002. Potent in vitro antimalarial activity of metacycloprodigiosin isolated from Streptomyces spectabilis BCC4785. Antimicrob. Agents Chemother. 46, 1112–1113.
Jain, T.C., Dingerdissen, J.J., and Weisbach, J.A. 1977. Isolation and structure elucidation of Gancidin W. Heterocycles 7, 341–346.
Jochen, W., Dajana, H., David, B.H., Ewald, B., and Hassan-Jomaa, A. 2002. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin. Antimicrob. Agents Chemother. 46, 2889–2894.
Joy, D., Feng, X., and Mu, J. 2003. Early origin and recent expansion of Plasmodium falciparum. Science300 5617, 318–321.
Keiser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. 2000. Practical Streptomyces Genetics (2nd ed.). John Innes Foundation. Norwich, England.
Kurosawa, Y., Dorn, A., Kitsuji-Shirane, M., Shimada, H., Satoh, T., Matile, H., Hofheinz, W., Masciadri, R., Kansy, M., and Ridley, R.G. 2000. Hematin polimerization assay as a high-throughput screen for identification of new antimalarial pharmacophores. Antimicrob. Agents Chemother. 44, 2638–2644.
Lipsitch, M., Tchetgen, E., and Cohen, T. 2010. Negative controls: A tools of detecting confounding and bias in observational studies. Epidemiology 21, 383–388.
Magyar, A., Zhang, X., Abdi, F., Kohn, H., and Widger, W. 1999. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant Rho proteins. J. Biol. Chem. 274, 7316–7324.
Peters, W. and Robinson, B.L. 1992. The chemotherapy of rodent malaria XLVII: studies on pyronaridine and other mannich base antimalarials. Ann. Trop. Med. Parasitol. 86, 455–465.
Pillay, D. and Zambon, M. 1998. Antiviral drug resistance. British Med. J. 317, 660–662.
Prudhomme, J., McDaniel, E., Ponts, N., Bertani, S., Fenical, W., Jensen, P., and Karine, L.R. 2008. Marine Actinomycete: A new source of compounds against the human malarial parasite. PLoS One 3, e2335.
Rajendra, P.M., Elisabeth, H., Oliver, K., Heinz, H.F., Armin, M., Andreas, B., and Hartmut, L. 2004. Anti-cancer and antibacterial trioxacarcins with high anti-malarial activity from a marine Streptomycete and their absolute stereochemistry. J. Antibiot. 57, 771–779.
Rhee, K.H. 2002. Isolation and characterization of Streptomyces sp. KH-614 producing anti-VRE (vancomycin-resistant enterococci) antibiotics. J. Gen. Appl. Microbiol. 48, 321–327.
Smaoui, S., Mathieu, F., Elleuch, L., Coppel, Y., Merlina, G., Karray- Rebai, I., and Mellouli, I. 2012. Taxonomy, purification and chemical characterization of four bioactive compounds from new Streptomyces sp. TN256 strain. World J. Microbiol. Biotechnol. 28, 793–804.
Strobel, G. and Daisy, B. 2003. Bioprospecting for microbial endophytes and their natural products microbial. Microbiol. Mol. Biol. Rev. 67, 491–502.
Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W., and Kopple, K.D. 2002. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615–2623.
Wangchuk, P., Bremner, J., Samten, B., Rattanajak, R., and Kamchonwongpaisan, S. 2010. Antiplasmodial agents from the Bhutanese medicinal plant Corydalis calliantha. Phytother. Res. 24, 481–485.
Wellems, T.E. 2002. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Science298 5591, 124–126.
Yotoko, K.S.C. and Elisei, C. 2006. Malaria parasites (Apicomplexa, Haematozoea) and their relationships with their hosts: is there an evolutionary cost for the specialization. J. Zool. System. Evol. Res. 44, 265–270.
Zainal-Abidin, B.A.H., Noorakmal, Z., and Othman, O. 1985. Ph. D. Thesis. National University of Malaysia, UKM Bangi Selangor, Malaysia.
Zin, N.M., Loi, C.S., Sarmin, N.M., and Rosli, A.N. 2010. Cultivation- dependent characterization of endophytic actinomycetes. Res. J. Microbiol. 5, 717–724.
Zin, N.M., Ng, K.T., Sarmin, N.I., Getha, K., and Tan, G.Y. 2011. Anti-trypanosoma activity of endophytic Streptomycete. Curr. Res. Bacteriol. 4, 1–8.
About this article
Cite this article
Baba, M.S., Zin, N.M., Hassan, Z.A.A. et al. In vivo antimalarial activity of the endophytic actinobacteria, Streptomyces SUK 10. J Microbiol. 53, 847–855 (2015). https://doi.org/10.1007/s12275-015-5076-6
- Streptomyces SUK10